Thailand has signed an advance agreement with AstraZeneca to secure a supply of its Covid-19 vaccine and for local production with technology from the British-Swedish firm.

The agreement comes amid reports that AstraZeneca is preparing to conduct new global trials, after critics questioned aspects of an earlier trial that produced results showing up to 90% efficacy of the vaccine. However, CEO Pascal Soriot said he didn’t expect the additional trial to hold up regulatory approvals in the UK and European Union.

Full story: Bangkok Post

BANGKOK POST ONLINE REPORTERS